Lithium Americas Corp. (TSE:LAC) stock trades at a price to

New Post Public Reply Private Reply Replies (0) Message Board
Trustedbymany
302
Lithium Americas Corp. (TSE:LAC) stock trades at a price to book multiple of 7.38 times and will benefit greatly once operations at Caucharí-Olaroz begin
SmallCapPower | August 23, 2017: Lithium Americas Corp. (TSX: LAC) is a Canada-based resource company focused on the advancement of two significant lithium projects: the Cauchari-Olaroz project, located in Jujuy Province of Argentina, and the Lithium Nevada project, located in north-western Nevada, USA and on the manufacturing and sales of organoclay products from its plant located in Fernley, Nevada. The demand for lithium is substantial, and Lithium Americas can be a value pick in the lithium space as the demand for electronic vehicles is rising worldwide, in turn driving demand for lithium, a key component in electric car batteries.

Investment Thesis

Surging demand for Lithium
Strong Lithium prices owing to supply scarcity
Joint Venture with SQM
Positive Feasibility Study on Caucharí-Olaroz Project
Nevada Lithium Project
Surging demand for lithium

Demand for lithium has been surging consistently and is expected to grow 15% per year by 2025. Demand will remain strong on the back of automakers using lithium for electric vehicles. Additionally, the demand for lithium is outweighing the supply, which is an advantage for lithium mining companies. Today the lithium market is 182k tonnes, which is expected to increase to 3.1 million tonnes in 20 years.

Strong lithium prices owing to supply scarcity

Lithium prices are expected to stay strong and increase going forward as the demand outweighs the supply currently. Lithium prices have surged about 300% in China, with contract prices rising to over US$12,000/t LCE in 2016. Electric Vehicle penetration should increase by 14% by 2025 globally and 30% in Europe as the cost parity with conventional fuel vehicles will be reached in the next few years. Additionally, the barriers to entry in the lithium industry remain high, further supporting prices going forward.

Joint Venture with SQM

Lithium Americas partnered in a 50/50 JV with SQM to help build and operate the Caucharí-Olaroz lithium project. SQM is the largest producer of lithium brines, with over 20 years experience operating and expanding its world-class Atacama project in Chile. Lithium Americas can capitalize on its Argentinean relationships and operating expertise of SQM to build a lower-risk development approach.

Positive Feasibility Study on Caucharí-Olaroz Project

The feasibility study estimates an average annual production of 25,000 tpa battery-grade Li2CO3 with a project life of 40 years. The Probable reserves are estimated at about 1.5 million tonnes LCE at 698 mg/L Li. Capital costs and operating costs would amount to US$425 million and US$2,495/t Li2CO3. The average EBITDA is estimated at approximately US$233 million based on the lithium carbonate price assumption of US$12,000/t battery-grade Li2CO3. The project is expected to commence operations by 2019. Infrastructure and plants are being designed to be scaleable to a production capacity of 50,000 tpa of battery-grade lithium carbonate.

Nevada Lithium Project

The Lithium Nevada project is a clay-based lithium project and has been the subject of extensive exploration and processing development work. Lithium Americas has recently increased its technical team and is currently in the process of advancing permitting and exploration, in addition to the investigation of innovative lithium extraction and processing technologies that build on previous successful piloting studies for this project.

Financial Performance

Lithium Americas’ Organoclay sales have surged 860% YoY, to come in at US$1.6 million 2Q17 as compared to $0.2 million in the same quarter last year. Lithium Americas reported a net loss of US$9.7 million, or US$(0.03) per diluted share, versus a US$3.8 million loss, or US$(0.01) per diluted share, in 2Q16.

Outlook

The outlook for Lithium Americas remains positive as the demand for lithium carbonate is on the rise, and the Company will greatly benefit from the Caucharí-Olaroz and Nevada Lithium Projects once they commence operations. Its stock trades at a price to book multiple of 7.38x. Lithium Americas has surged ~35% YTD in 2017 while its peers (Lithium Juniors are down 3%) have lagged the Lithium Majors, which are up 67% on average in 2017.

Lithium Americas Corp. (LACDD) Stock Research Links

LACDD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 1

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 1

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading

Top 5 Most Recently Viewed Articles

Combining Forces: Waters Corporation and BD to Lead Diagnostics

Updated Category News Views 331

Exciting Merger in the Life Sciences Sector In a significant move for the life sciences industry, Waters Corporation (NYSE: WAT) has officially announced its plans to merge with BD (Becton, Dickinson and Company) (NYSE: BDX). This merger aims to create a leading entity in the fields of regulated and high-volume testing. The combination is expected to harness the strengths...

Continue Reading
Citius Oncology Strengthens LYMPHIR Launch with New Partnership

Updated Category News Views 109

Citius Oncology Reinforces Distribution for LYMPHIR Citius Oncology, Inc. (Nasdaq: CTOR), a leading company in oncology therapeutics, has taken a significant step by partnering with Cencora, a global provider of pharmaceutical solutions. The newly signed distribution services agreement is aimed at enhancing commercial infrastructure and ensuring the successful launch of...

Continue Reading
Exploring Growth in Low-Code Development Platforms

Updated Category News Views 242

Surging Growth in Low-Code Development Platforms The demand for low-code development platforms is on the rise, with projected growth from USD 26.30 billion in 2025 up to USD 67.12 billion by 2030, at an impressive CAGR of 20.61%. This surge is primarily fueled by organizations adopting hybrid and multi-cloud strategies, making low-code tools essential for modernizing...

Continue Reading
Foresee Pharmaceuticals Unveils Promising Results for Linvemastat

Updated Category News Views 58

Foresee Pharmaceuticals Announces Groundbreaking Phase 1 Results Foresee Pharmaceuticals (TPEx: 6576) is excited to share notable updates regarding its Phase 1 clinical trial of linvemastat (FP-020), a distinctive and selective oral MMP-12 inhibitor. The trial, focused on assessing safety, tolerability, and pharmacokinetics, has been successfully completed and has...

Continue Reading
Unlocking Spring’s Real Estate Potential with Mistoria Group

Updated Category News Views 302

Why May is the Optimal Time for Real Estate Transactions As the weather warms and spring settles in, the real estate market bursts with activity. Leading property experts suggest that May is the prime month to either buy or sell a home. Mish Liyanage, the CEO of Mistoria Group, emphasizes that emerging market trends provide compelling reasons for homeowners and potential...

Continue Reading